SCHEMBL991292

SCHEMBL991292

CC1(c2ccc(F)cc2)CO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.47
SLC6A2 P23975 3/20 0.47
CHRNA1 P02708 2/20 0.47
CHRNG P07510 2/20 0.47
CHRNB1 P11230 2/20 0.47
CHRNB2 P17787 2/20 0.47
CHRNB4 P30926 2/20 0.47
CHRNA3 P32297 2/20 0.47
CHRNA4 P43681 2/20 0.47
CHRND Q07001 2/20 0.47
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
PABPC1 P11940 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC6A4 P31645 2/20 0.36
ACHE P22303 1/20 0.36
HCAR3 P49019 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1499439 0.87 CHRNB2 (0.35) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL3509939 0.78 SLC6A2 (0.47) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL11489793 0.76 OPRM1 (0.34) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL8907842 0.76 SLC6A3 (0.46) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL8906999 0.76 SLC6A3 (0.46) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL990597 0.76 SLC6A4 (0.47) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL14142801 0.76 TAAR1 (0.47) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL3209284 0.76 TAAR1 (0.47) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL5698923 0.76 MAOA (0.46) SLC6A3SLC6A2MAOBMAOALMNA
SCHEMBL5698924 0.76 MAOA (0.46) SLC6A3SLC6A2MAOBMAOALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119080719-A Preparation method of polysubstituted olefin epoxy compound 广西科技大学 2024-12-06 CN disclosed
US-9550782-B2 Compounds and methods for treating diabetes MEDIVATION TECHNOLOGIES, INC. (US) 2017-01-24 US disclosed
US-9527854-B2 Compounds and methods for treatment of hypertension MEDIVATION TECHNOLOGIES, INC. (US) 2016-12-27 US disclosed
US-9481676-B2 Azepino[4,5-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-11-01 US disclosed
US-9469641-B2 Pyrido[3,4-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-10-18 US disclosed
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
CN-103476416-B The Compounds and methods for for the treatment of hypertension 梅迪维新技术公司 2016-09-21 CN disclosed
US-9409910-B2 Azepino[4,5-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-08-09 US disclosed
EP-1080062-B1 PROCESS FOR THE PREPARATION OF 2-HYDROXYALKYL HALOPHENONES AVECIA LTD (GB) 2003-12-10 EP disclosed
US-6362376-B1 2-BENZYLOXYALKYL HALOPHENONES AS CHIRAL INTERMEDIATES FOR 2-HYDROXYALKL HALOPHENONES AVECIA LIMITED (GB) 2002-03-26 US disclosed
US-6300522-B1 CONDENSING 2-CHLOROALKANOIC ACID WITH OPTIONALLY SUBSTITUTED BENZYL ALCOHOL TO FORM 2-BENZYLOXYALKANOIC ACID, CONVERTING TO ACID CHLORIDE, REACTING WITH GRIGNARD REAGENT IN PRESENCE OF CUPROUS COMPOUND, HYDROGENATING TO REMOVE BENZYL GROUP AVECIA LIMITED (GB) 2001-10-09 US disclosed
EP-1080062-A1 PROCESS FOR THE PREPARATION OF 2-HYDROXYALKYL HALOPHENONES Avecia Limited (GB) 2001-03-07 EP disclosed
WO-1999054272-A1 PROCESS FOR THE PREPARATION OF 2-HYDROXYALKYL HALOPHENONES AVECIA LIMITED (GB) 1999-10-28 WO disclosed
EP-0126430-B1 PROCESS FOR THE PREPARATION OF 1-TRIAZOLYLETHYLETHER-DERIVATIVES, AND MICROBICIDAL COMPOSITIONS CONTAINING NOVEL 1-TRIAZOLYL-PHENOXYPHENYLETHYLETHER-DERIVATIVES AS ACTIVE INGREDIENTS AND THEIR USE CIBA-GEIGY AG (CH) 1991-08-28 EP disclosed
US-4945100-A Process for the preparation of 1-triazolylethyl ether derivatives CIBA-GEIGY CORPORATION (US) 1990-07-31 US disclosed
US-4621150-A METAL PERHALATE OR SULFONATE OR COMPLEX; GLYCIDATE, 2-HYDROXY-3-BUTENOATE, EPOXIDE SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-11-04 US disclosed
EP-0153692-A2 Method for isomerization a glycidate derivative SAGAMI CHEMICAL RESEARCH CENTER (JP) 1985-09-04 EP disclosed
EP-0126430-A2 Process for the preparation of 1-triazolylethylether-derivatives, and microbicidal compositions containing novel 1-triazolyl-phenoxyphenylethylether-derivatives as active ingredients and their use CIBA-GEIGY AG (CH) 1984-11-28 EP disclosed